What amount sold does INVALVE THERAPEUTICS DEDICATED FUND, LP report in Form D filings?

The latest linked filings report $220K sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was INVALVE THERAPEUTICS DEDICATED FUND, LP's most recent SEC filing?

INVALVE THERAPEUTICS DEDICATED FUND, LP's most recent Form D filing was on 2021-02-08.

How many investors does INVALVE THERAPEUTICS DEDICATED FUND, LP have?

The most recent Form D filing lists 2 investor(s).

What type of securities does INVALVE THERAPEUTICS DEDICATED FUND, LP offer?

INVALVE THERAPEUTICS DEDICATED FUND, LP's SEC Form D filings indicate equity offerings.

INVALVE THERAPEUTICS DEDICATED FUND, LP

CIK: 0001844156·Investing·LOUISVILLE, KY·Limited Partnership·Founded 2020

Reported Sold

$220,000

Total Filings

Identified Offerings

Last Filed

Feb 8, 2021

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Investing industry

SEC EDGAR

Offering filing timeline

Feb 8, 2021Form D — New notice

Reported sold: $220,000 · Target: $300,000

Rule 506(b)·2 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$220,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

William Spence

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Feb 8, 2021	New	$300,000	$220,000	2

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

HTD Health Holding LLC

Investing

Offering target: $179,939

Filed Oct 8, 2026